Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? (2021)
- Authors:
- Autor USP: COSTA, DIEGO LUÍS - FMRP
- Unidade: FMRP
- DOI: 10.3389/fcimb.2021.672527
- Subjects: AGENTES ANTIMICROBIANOS; ANTÍGENOS DE BACTÉRIAS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSE; VACINAS; FARMACOTERAPIA
- Keywords: Tuberculosis; Host-directed therapy; Adaptive immunity; CD4+ T lymphocytes; IFN-g; TNF; IL-12
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Cellular and Infection Microbiology
- ISSN: 2235-2988
- Volume/Número/Paginação/Ano: v. 11, art. 672527, p. 1-12, 2021
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
COSTA, Diego Luís et al. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work?. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.672527. Acesso em: 27 mar. 2026. -
APA
Costa, D. L., Amaral, E. P., Namasivayam, S., Mittereder, L. R., Andrade, B. B., & Sher, A. (2021). Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? Frontiers in Cellular and Infection Microbiology, 11, 1-12. doi:10.3389/fcimb.2021.672527 -
NLM
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 mar. 27 ] Available from: https://doi.org/10.3389/fcimb.2021.672527 -
Vancouver
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 mar. 27 ] Available from: https://doi.org/10.3389/fcimb.2021.672527 - The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model
- Host-Directed Therapies for Tuberculosis [Editoria]
- Editorial: The heme oxygenase system in immunity
- Modulation of inflammation and immune responses by heme oxygenase-1: implications for infection with intracellular pathogens
- Caracterização da função de células T reguladoras em pacientes infectados com Leishmania braziliensis
- Caracterização da infecção experimental de camundongos com isolados de Leishmania braziliensis resistentes e suscetíveis ao antímônio e ao óxido nítrico
- Crosstalk between heme oxygenase-1 and iron metabolism in macrophages: implications for the modulation of inflammation and immunity
- Recent advances in host-directed therapies for tuberculosis and malaria
- Mycobacterium tuberculosis induces Irg1 in murine macrophages by a pathway involving both TLR-2 and STING/IFNAR signaling and requiring bacterial phagocytosis
- Limitation of deleterious iNOS-Expressing interstitial macrophages is dependent on protective IL-1α and IL-17 in tuberculosis and existing obesity
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003229906.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
